EA002352B1 - Производные индазоламида в качестве серотонинергических агентов - Google Patents

Производные индазоламида в качестве серотонинергических агентов Download PDF

Info

Publication number
EA002352B1
EA002352B1 EA199900935A EA199900935A EA002352B1 EA 002352 B1 EA002352 B1 EA 002352B1 EA 199900935 A EA199900935 A EA 199900935A EA 199900935 A EA199900935 A EA 199900935A EA 002352 B1 EA002352 B1 EA 002352B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
formula
pharmaceutically acceptable
alkyl
group
Prior art date
Application number
EA199900935A
Other languages
English (en)
Russian (ru)
Other versions
EA199900935A1 (ru
Inventor
Алессандра Алиси
Марио Бруфани
Никола Каццолла
Марилена Джаннанджели
Марио Пинца
Original Assignee
Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. filed Critical Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Publication of EA199900935A1 publication Critical patent/EA199900935A1/ru
Publication of EA002352B1 publication Critical patent/EA002352B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)
EA199900935A 1997-04-15 1998-04-02 Производные индазоламида в качестве серотонинергических агентов EA002352B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000867A IT1291569B1 (it) 1997-04-15 1997-04-15 Indazolammidi come agenti serotoninergici
PCT/EP1998/002129 WO1998046589A2 (en) 1997-04-15 1998-04-02 Indazole amide compounds as serotoninergic agents

Publications (2)

Publication Number Publication Date
EA199900935A1 EA199900935A1 (ru) 2000-04-24
EA002352B1 true EA002352B1 (ru) 2002-04-25

Family

ID=11376888

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900935A EA002352B1 (ru) 1997-04-15 1998-04-02 Производные индазоламида в качестве серотонинергических агентов

Country Status (26)

Country Link
US (1) US6197769B1 (cg-RX-API-DMAC7.html)
EP (1) EP0975623B1 (cg-RX-API-DMAC7.html)
JP (2) JP4578581B2 (cg-RX-API-DMAC7.html)
KR (1) KR100563867B1 (cg-RX-API-DMAC7.html)
CN (1) CN1318416C (cg-RX-API-DMAC7.html)
AR (1) AR012426A1 (cg-RX-API-DMAC7.html)
AT (1) ATE219490T1 (cg-RX-API-DMAC7.html)
AU (1) AU740360B2 (cg-RX-API-DMAC7.html)
BG (1) BG64006B1 (cg-RX-API-DMAC7.html)
CA (1) CA2286870C (cg-RX-API-DMAC7.html)
CZ (1) CZ295190B6 (cg-RX-API-DMAC7.html)
DE (1) DE69806141T2 (cg-RX-API-DMAC7.html)
DK (1) DK0975623T3 (cg-RX-API-DMAC7.html)
EA (1) EA002352B1 (cg-RX-API-DMAC7.html)
ES (1) ES2178205T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20022654B (cg-RX-API-DMAC7.html)
HU (1) HU227973B1 (cg-RX-API-DMAC7.html)
IL (1) IL132127A (cg-RX-API-DMAC7.html)
IT (1) IT1291569B1 (cg-RX-API-DMAC7.html)
PL (1) PL193308B1 (cg-RX-API-DMAC7.html)
PT (1) PT975623E (cg-RX-API-DMAC7.html)
SK (1) SK284731B6 (cg-RX-API-DMAC7.html)
TR (1) TR199902546T2 (cg-RX-API-DMAC7.html)
UA (1) UA58550C2 (cg-RX-API-DMAC7.html)
WO (1) WO1998046589A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA982926B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
MXPA03007621A (es) 2001-02-23 2003-12-04 Merck & Co Inc Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
EP1390034A4 (en) * 2001-04-03 2005-07-13 Merck & Co Inc N-SUBSTITUTED NONARYL HETEROCYCLO AMIDYL-NMDA / NR2B ANTAGONISTS
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
DE602005014566D1 (de) * 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen
US20060183901A1 (en) * 2005-02-17 2006-08-17 Theravance, Inc. Crystalline form of an indazole-carboxamide compound
BRPI0608392A2 (pt) * 2005-03-02 2009-12-29 Theravance Inc compostos de quinolinona como agonistas do receptor 5-ht4
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
US8377968B2 (en) * 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
CA2833507A1 (en) * 2011-06-07 2012-12-13 Dainippon Sumitomo Pharma Co., Ltd. Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
WO2013124169A1 (en) * 2012-02-21 2013-08-29 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
EA024939B1 (ru) * 2012-02-21 2016-11-30 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. 1h-индазол-3-карбоксамидные соединения в качестве ингибиторов гликогенсинтазы киназы 3-бета
WO2014134306A1 (en) 2013-03-01 2014-09-04 Zalicus Pharmaceuticals, Ltd. Heterocyclic inhibitors of the sodium channel
WO2021007487A1 (en) 2019-07-11 2021-01-14 Praxis Precision Medicines, Inc. Formulations of t-type calcium channel modulators and methods of use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0501322A1 (en) * 1991-02-25 1992-09-02 Glaxo Group Limited 3-Piperidinylmethylcarboxylate substituted indoles
WO1993003725A1 (en) * 1991-08-20 1993-03-04 Smithkline Beecham Plc 5-ht4 receptor antagonists
EP0732333A1 (en) * 1995-03-16 1996-09-18 Eli Lilly And Company Indazolecarboxamides
WO1996038420A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amino group

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0501322A1 (en) * 1991-02-25 1992-09-02 Glaxo Group Limited 3-Piperidinylmethylcarboxylate substituted indoles
WO1993003725A1 (en) * 1991-08-20 1993-03-04 Smithkline Beecham Plc 5-ht4 receptor antagonists
EP0732333A1 (en) * 1995-03-16 1996-09-18 Eli Lilly And Company Indazolecarboxamides
WO1996038420A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amino group

Also Published As

Publication number Publication date
JP5237324B2 (ja) 2013-07-17
EA199900935A1 (ru) 2000-04-24
HK1027811A1 (en) 2001-01-23
SK284731B6 (sk) 2005-10-06
HUP0002057A2 (hu) 2001-04-28
EP0975623B1 (en) 2002-06-19
WO1998046589A2 (en) 1998-10-22
BG64006B1 (bg) 2003-09-30
KR20010006120A (ko) 2001-01-26
HU227973B1 (hu) 2012-07-30
ITMI970867A1 (it) 1998-10-15
CZ362599A3 (cs) 2000-04-12
DE69806141T2 (de) 2003-01-30
AU740360B2 (en) 2001-11-01
US6197769B1 (en) 2001-03-06
IL132127A (en) 2005-06-19
CA2286870C (en) 2007-05-22
DK0975623T3 (da) 2002-10-14
JP2010195813A (ja) 2010-09-09
KR100563867B1 (ko) 2006-03-24
IT1291569B1 (it) 1999-01-11
PT975623E (pt) 2002-10-31
AU7215998A (en) 1998-11-11
UA58550C2 (uk) 2003-08-15
SK142399A3 (en) 2000-08-14
EP0975623A2 (en) 2000-02-02
ATE219490T1 (de) 2002-07-15
DE69806141D1 (de) 2002-07-25
PL193308B1 (pl) 2007-01-31
CZ295190B6 (cs) 2005-06-15
WO1998046589A3 (en) 1999-01-28
CN1252798A (zh) 2000-05-10
JP4578581B2 (ja) 2010-11-10
IL132127A0 (en) 2001-03-19
JP2001518906A (ja) 2001-10-16
GEP20022654B (en) 2002-03-25
ES2178205T3 (es) 2002-12-16
CN1318416C (zh) 2007-05-30
AR012426A1 (es) 2000-10-18
PL336348A1 (en) 2000-06-19
CA2286870A1 (en) 1998-10-22
ZA982926B (en) 1998-10-09
TR199902546T2 (xx) 2000-05-22
HUP0002057A3 (en) 2002-01-28
BG103863A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
JP5237324B2 (ja) セロトニン様作用薬としてのインダゾールアミド化合物
US5652246A (en) Piperidine compounds
DE69413542T2 (de) Perhydroisoindolderivate als substanz p antagonisten
DE69111029T2 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.
DE69008012T2 (de) 4-Fluorbenzolderivate, Herstellungsverfahren und diese enthaltende pharmazeutische Zusammensetzungen.
DE60309852T2 (de) Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden
KR20040103973A (ko) N-[페닐(피페리딘-2-일)메틸]벤즈아미드의 유도체, 그의제조 방법 및 치료법에서의 그의 용도
DE69417427T2 (de) Indol- und indolin-derivate als 5ht1d rezeptor antagonisten
JPS6289679A (ja) ピペリジン誘導体
JPS63146874A (ja) インドール誘導体
JP2005525332A (ja) 5−ht6受容体アフィニティーを有するスルホニル化合物
DE69311165T2 (de) Kondensierte heterocyclische Ketonderivate, ihre Herstellung und ihre Verwendung
DE602004007672T2 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
EP0937715B1 (en) Tetrahydrobenzindole compounds
MXPA05010288A (es) Derivados de bencenosulfonamida, metodo para su produccion y uso de los mismos para el tratamiento del dolor.
DE69829317T2 (de) Tetrahydrobenzindol-derivate
JPH11504921A (ja) ニューロキニンアンタゴニストとしてのピペラジノ誘導体
DE69011602T2 (de) Substituierte 4-Aminochinoline.
EP0187619A2 (de) 1,3-disubstituierte Tetrahydropyridine
US5192763A (en) [(1-arylpyrrolidin-2-yl)methyl]piperazine derivatives, their preparation and their application in therapeutics
HK1027811B (en) Indazole amide compounds as serotoninergic agents
MXPA99009422A (en) Indazole amide compounds as serotoninergic agents
EP0187122A2 (de) 1,3,4-Trisubstituierte Azacycloalkane bzw. Azacycloalkene
MXPA97006826A (en) Esteres y amidas of 1,4-piperidina di-sustitu

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU